Wang Xiuzhe, Puerta Elena, Cedazo-Minguez Angel, Hjorth Erik, Schultzberg Marianne
Department of Neurobiology, Care Sciences and Society, Section of Neurodegeneration, Karolinska Institutet, 141 86, Stockholm, Sweden.
J Mol Neurosci. 2015 Feb;55(2):396-405. doi: 10.1007/s12031-014-0346-z. Epub 2014 Jun 10.
Aging is the primary risk factor for Alzheimer's disease (AD), and it is known that inflammation is associated with both aging and AD. To resolve inflammation, biosynthesis of the specialized pro-resolving mediators (SPMs) is enhanced in a programmed and active manner. We investigated the effect of age on resolution by analyzing hippocampal tissue from 2- and 9-month-old senescence-accelerated mouse prone 8 (SAMP8), as well as age-matched senescence-accelerated mouse resistant 1 (SAMR1). Pro-inflammatory markers increased upon age in SAMP8 mice and were also higher than those in age-matched SAMR1 mice. However, neither SPMs nor their receptors were enhanced upon age in SAMP8 mice compared to age-matched SAMR1 mice. Analysis of SPM biosynthetic enzymes revealed elevated levels of leukocyte type 12-lipoxygenase (L12-LOX) and decreased 5-LOX levels upon age in SAMR1 mice, whereas they remained unchanged in SAMP8 mice. Moreover, we found partial co-localization of L12-LOX and amyloid beta (Aβ) staining, as well as correlation between L12-LOX and phosphorylated tau levels in SAMP8, but not SAMR1 mice. Thus, we conclude that the resolution response in SAMP8 mice is insufficient to counteract the increased inflammation with age, and this may have a role in the development of AD-like pathologies.
衰老为阿尔茨海默病(AD)的主要风险因素,且已知炎症与衰老及AD均相关。为解决炎症问题,专门的促消退介质(SPM)的生物合成以程序化且活跃的方式得到增强。我们通过分析2月龄和9月龄的衰老加速易患8型小鼠(SAMP8)以及年龄匹配的衰老加速抗性1型小鼠(SAMR1)的海马组织,研究了年龄对炎症消退的影响。在SAMP8小鼠中,促炎标志物随年龄增长而增加,且也高于年龄匹配的SAMR1小鼠中的水平。然而,与年龄匹配的SAMR1小鼠相比,SAMP8小鼠中SPM及其受体均未随年龄增长而增强。对SPM生物合成酶的分析显示,SAMR1小鼠中白细胞12型脂氧合酶(L12-LOX)水平随年龄增长而升高,5-LOX水平降低,而在SAMP8小鼠中这些酶水平保持不变。此外,我们发现SAMP8小鼠(而非SAMR1小鼠)中L12-LOX与淀粉样β蛋白(Aβ)染色存在部分共定位,以及L12-LOX与磷酸化tau水平之间存在相关性。因此,我们得出结论,SAMP8小鼠中的炎症消退反应不足以抵消随年龄增长而增加的炎症,这可能在AD样病理的发展中起作用。